BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17121994)

  • 1. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.
    Choi YH; Bernardi R; Pandolfi PP; Benveniste EN
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18715-20. PubMed ID: 17121994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
    Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
    PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of promyelocytic leukemia protein in the ethanol-induced apoptosis in mouse embryo fibroblasts.
    Wang LH; Yang JY; Cui W; Shin YK; Wu CF
    Yakugaku Zasshi; 2008 Jul; 128(7):1067-71. PubMed ID: 18591875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML control of cytokine signaling.
    Maarifi G; Chelbi-Alix MK; Nisole S
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):551-61. PubMed ID: 24861946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus.
    Djavani M; Rodas J; Lukashevich IS; Horejsh D; Pandolfi PP; Borden KL; Salvato MS
    J Virol; 2001 Jul; 75(13):6204-8. PubMed ID: 11390623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
    Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
    Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
    Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
    Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EVI1 abrogates interferon-alpha response by selectively blocking PML induction.
    Buonamici S; Li D; Mikhail FM; Sassano A; Platanias LC; Colamonici O; Anastasi J; Nucifora G
    J Biol Chem; 2005 Jan; 280(1):428-36. PubMed ID: 15519999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
    Cheng X; Liu Y; Chu H; Kao HY
    J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin inhibits IFN-gamma-induced CD40 gene expression by suppressing STAT-1alpha.
    Lee SJ; Qin H; Benveniste EN
    J Leukoc Biol; 2007 Aug; 82(2):436-47. PubMed ID: 17507688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
    Samanta A; Qian X; Greene MI
    DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.
    Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H
    Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
    Lavau C; Marchio A; Fagioli M; Jansen J; Falini B; Lebon P; Grosveld F; Pandolfi PP; Pelicci PG; Dejean A
    Oncogene; 1995 Sep; 11(5):871-6. PubMed ID: 7545807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
    Masroori N; Merindol N; Berthoux L
    Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.